Delfi Diagnostics, Inc. funding
Delfi Diagnostics, Inc., a biotechnology company based in Palo Alto, CA, filed a Form D with the SEC on December 18, 2025 and reported $34.3M raised of a $60M offering.
Amount raised$34.3M
Offering size$60M
Filed with the SECDecember 18, 2025
First saleDecember 1, 2025
IndustryBiotechnology
SecuritiesDebt
LocationPalo Alto, CA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far50
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Dec 18
Other health care rounds in California
Alpfa Medical, Inc.$80.3M · Sep 28Other Health CareBigHat Biosciences, Inc.$75.1M · Oct 26BiotechnologyCaspian Therapeutics, Inc.$50M · Sep 23BiotechnologyEstuary Biotherapeutics, Inc.$40.7M · Oct 16BiotechnologyPFARADIGM Health, Inc.$31.1M · Sep 28Other Health CareTrellis Bioscience, Inc.$22.9M · Oct 21BiotechnologyAltay Therapeutics, Inc.$15.7M · Oct 2BiotechnologyAdela, Inc.$12M · Oct 19Biotechnology